Purchase Order 75N91018P00531
Award Date 7/25/18
Potential Completion Date 8/25/18
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute issued a purchase order to Proteinsimple valued at $14,236.04 on April 11, 2018, for a firm fixed price award with an ultimate completion date of May 9, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order procures specialized protein analysis products from Proteinsimple, a manufacturer of advanced scientific equipment for biomedical research, including western blotting systems and capillary gel electrophoresis units.</p>
- <p>The National Cancer Institute awarded a purchase order to Proteinsimple for $23,849.28 on January 17, 2019, with completion by February 18, 2019. The order is a firm fixed-price commercial item purchase with no set-aside designation. Performance occurs in San Jose, California. Proteinsimple manufactures specialized protein analysis equipment and associated services for biomedical research, including western blotting systems and capillary gel electrophoresis units.</p>
- <p>The National Cancer Institute awarded a purchase order to Proteinsimple valued at $5,000.00 on March 29, 2016, for de-obligation of expiring FY2016 funds. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of April 8, 2016.</p>
- <p>The National Cancer Institute awarded a purchase order to ProteinSimple for a capillary-based nano-immunoassay, valued at $25,000, on August 9, 2017. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 31, 2017. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
- This federal contract award to Proteinsimple, also known as Bio-Techne Corporation Division, is for the provision of specialized protein analysis products and services to the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS). The contract, valued at $123,677.94, is for a firm-fixed-price purchase order to supply software and maintenance services for the SW0108 and SW0111 systems. The award has no set-aside designation and is effective from the...
- This firm fixed-price purchase order, awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, requires the contractor Proteinsimple (a division of Bio-Techne Corporation) to provide all labor, material, and equipment necessary to maintain two government-owned Peggy Sue capillary-based immunoassay instruments. The contract has a ceiling value of $103,601.43 and runs through August 31, 2024. No set-aside was used for this award....
- This $13,912 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Proteinsimple, a subsidiary of Bio-Techne Corporation. The contract is for Proteinsimple's JESS Western Blotting Instrument, a specialized protein analysis system used in biomedical research and drug development. The contract does not have a set-aside designation, indicating open competition. Proteinsimple...
- This is a $58,152.16 firm fixed price purchase order contract awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the Department of Health and Human Services, to Proteinsimple, a subsidiary of Bio-Techne Corporation. The contract is for a PROTEINSIMPLE BIO-TECHNE SERVICE AGREEMENT 2024 NEW AWARD with a period of performance through June 30, 2028. Proteinsimple is a leading manufacturer and provider of specialized protein analysis...
- <p>The National Cancer Institute issued a purchase order to Proteinsimple valued at $42,914.96 for reagents and assays for Peggy Sue instruments, awarded September 18, 2017, with completion by November 17, 2017. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Proteinsimple on July 24, 2017, for $20,655.00 under firm fixed-price pricing. The order calls for protein analysis products and services. Place of performance is Hamilton, Montana. The order was due for completion by August 11, 2017. Proteinsimple operates as a subsidiary of Bio-Techne Corporation and is a manufacturer of specialized protein analysis equipment including western blotting systems, capillary...